Monoclonal antibodies that stop the coronavirus from spreading in the body are among promising strategies for averting severe illness from Covid-19 before vaccines arrive, said Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases. Here are a few excerpts and you can follow the link below to see the interview on YouTube.
“We are focusing very heavily now on treatment of early infection and, or prevention of infection,” Fauci told the Journal of the American Medical Association in an interview Friday. “And that’s the bridge to the vaccine.”
“We have some cautious optimism that monoclonal antibodies may be an important therapeutic for early disease,” Fauci said Sept. 10 in an online briefing for Massachusetts General Hospital staff. “We need something to keep people out of the hospital.”